Company
Headquarters: Jinan, China
Employees: 245
CN¥177.7 Million
CNY as of June 1, 2022
US$26.7 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Shandong Jintai Group Co., Ltd. produces and distributes chemical reagent medicines in China. The company provides tablets, capsules, ointments, membranes, and others. It is also involved in the enterprise investment business, as well as in the provision of leasing services. The company is based in Jinan, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Shandong Jintai Group Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600385 wb_incandescent